Are there generic versions of Vandetanib?

Vandetanib (Vandetanib) is a cancer drug used in adults and children over 5 years of age to treat medullary thyroid cancer, a cancer that starts in the cells in the thyroid gland that produce the hormone calcitonin. This medication is used when the disease is spreading rapidly and causing symptoms, and when the cancer cannot be removed with surgery and has developed or spread to other parts of the body. Vandetanib contains the active substance vandetanib.

Medullary thyroid carcinoma is a neuroendocrine tumor arising from the parafollicular cells of the thyroid gland and is characterized by excessive secretion of calcitonin. In large clinical trials of vandetanib, routine liver test abnormalities were common with elevated serum aminotransferases, occurring in up to half of the patients and occurring five times more than the upper limit of normal (ULN) 2% to 5% of patients. In prelicensure trials of vandetanib in thyroid cancer, there were no reports of clinically apparent liver injury with jaundice or liver failure. However, many kinase inhibitors used in cancer chemotherapy are associated with clinically apparent cases of liver injury, which typically develops within the first 2 to 12 weeks of treatment and manifests as symptoms of fatigue, nausea, and jaundice and a hepatocellular pattern of elevated serum enzymes without immunoallergic or autoimmune features.

The original drug vandetanib has not yet been marketed in China, so it is not included in medical insurance. The original drug specifications of vandetanib listed overseasThe price of each box of 300mg*30 tablets may be more than 30,000 yuan (the price may fluctuate due to the exchange rate). There is currently no generic drug of vandetanib produced and launched. For more drug information and specific prices, please consult the medical consultant of Yaode.